• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld

BioWorld

Nov. 28, 2011

View Archived Issues

Transcept's Roller Coaster Year Ends with Intermezzo Approval

Back in July, it looked like Transcept Pharmaceutical Inc.'s insomnia drug Intermezzo (zolpidem tartrate) was down for the count. The company, aiming to provide the first treatment specifically for middle-of-the-night waking, had just gotten a surprise second complete response letter (CRL), despite conducting the FDA-requested next-day highway driving study. Read More

Macrocycles: Going Where No Drugs Have Gone Before

Big pharma and biotech start-ups have embarked on a federated mission to explore the expansive chemical space between small molecules and biologics to seek out new therapies that will boldly go where no drugs have gone before. Read More

BPI Combination Treatment Eyed for Radiation Sickness

Combination treatment with Bactericidal/Permeability-Increasing protein (BPI) and an antibiotic that is the veterinary equivalent of Cipro (ciprofloxacin, Bayer AG) – was able to save three-quarters of mice subjected to radiation levels that almost unfailingly killed their untreated cousins. Read More

Inspiration Launches Second Trial of OBI-1 in Hemophilia A

Inspiration Biopharmaceuticals Inc. initiated patient enrollment in the second of two pivotal studies of the company's OBI-1 Accur8 Phase III hemophilia program. Read More

Holiday Notice

BioWorld's offices were closed Thurday, Nov. 24, and Friday, Nov. 25, in observance of the Thanksgiving Day holiday in the U.S. No issues were published those days. Read More

Financings Roundup

• Radius Health Inc., of Cambridge, Mass., closed a second tranche of a three-tranche financing worth $91 million total. The second close includes $21.4 million in equity financing by current investors and $6.25 million in debt financing. Proceeds will fund the ongoing Phase III trial of BA058 for osteoporosis. Read More

Other News To Note

• Cipher Pharmaceuticals Inc., of Mississauga, Ontario, submitted an amendment to its pending new drug application to the FDA for cip-isotretinoin, which is in development for the treatment of acne. The amendment includes additional clinical information requested by the FDA. Acceptance by the FDA as a complete response will trigger a $1 million milestone payment from Cipher's marketing partner. Read More

Stock Movers

Read More

Clinic Roundup

• Neuralstem Inc., of Rockville, Md., dosed its first patient in a trial of a stem cell therapy in the cervical region of the spine in an ongoing safety trial in amyotrophic lateral sclerosis. The previous 12 patients in the study received stem cell transplants in the lumbar region of the spine, but patient 13 received the transplant in the gray matter of the cervical region. Read More

Bench Press

The innate immune system has two competing jobs. On one hand, it tries to limit the replication of viruses and bacteria. But on the other, it has to make sure there is enough antigen around to get the adaptive immune system going. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • 3D heart in chest

    At CRVBC 2025: Aging is circulating in your blood

    BioWorld Science
    All kinds of substances circulate through the bloodstream. Some are beneficial, like oxygen or nutrients, and others less so, like waste products, toxins,...
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe